Medipure is a Canada-based biopharmaceutical company that discovers and develops proprietary endocannabinoid system-based prescription drugs for targeted diseases... Read more
Medipure is a Canada-based biopharmaceutical company that discovers and develops proprietary endocannabinoid system-based prescription drugs for targeted diseases... Read more
CEO
Boris Weiss
Est. Annual Revenue
<$1M
Est. Employees
<10
News
Jun 28, 2021
PRWeb
Press Release: Medipure Pharmaceuticals : Medipure Holdings Inc. Announces Walter Berukoff and Denis J. Gallagher Formally Join Company's Board of Directors
May 26, 2021
CFN Media Group
Medipure Pharmaceuticals: Medipure Holdings Inc. Announces a Filing of its Provisional Patent for Proprietary Prodrug Platform for Various Therapeutics
May 19, 2021
StreetInsider
Press Release: Medipure Pharmaceuticals : Medipure Holdings Inc. Announces a Filing of its Provisional Patent for Psoriasis Treatment
Mar 16, 2021
StreetInsider
Press Release: Medipure Pharmaceuticals : Medipure Holdings Inc. Announces Walter Berukoff to Serve as Special Advisor to Company's Board of Directors
Mar 11, 2021
PRWeb
Press Release: Medipure Pharmaceuticals : Medipure Holdings Inc.'s Proprietary Medications to Provide Solutions for Global Opioid Pandemic While Contributing Positive Social Impact
Mar 01, 2021
StreetInsider
Press Release: Medipure Pharmaceuticals : Medipure Holdings Inc. Announces a Milestone for its Proprietary Anxiety and Mood Disorder Medication
Aug 15, 2016
FinanzNachrichten
Medipure: CSE: 2016-0817 - Delist - Medipure Holdings Inc. (MDH)
May 02, 2016
FinanzNachrichten
Medipure: CSE: 2016-0502 - Suspension - Medipure Holdings Inc. (MDH)
Nov 05, 2015
CNW GROUP LTD
Press Release: Medipure : IIROC Trading Halt - MDH; MLK
Aug 21, 2015
MARKETWIRED
Press Release: Medipure : A Major Shareholder Acquires Additional Medipure Shares